Special Report about Chile to appear in Pharmaceutical Executive
Release Date: 2010-11-25
Santiago, Chile. November 20, 2010 - Focus Reports, the contract-publishing unit of Focus Communication, is currently preparing a special feature on the Chilean Pharmaceutical Industry. Due to be released next winter, the special Chilean issue follows similar successful reports that Focus Reports has prepared in Latin America such as Mexico, Brazil, Argentina and Colombia.
As the 6th largest pharma market in Latin America, Chile recently revamped its national health program (known as “GES”) to improve the competitiveness of its pharmaceutical and health care market. Focus Reports will look at which opportunities for growth that Chile stands to benefit from in the pharmaceutical sector. What have the authorities planned for the optimization of the market to create a more efficient and effective regulatory environment? What is the potential of developing the clinical trial market in Chile to turn the country into a strategic hub in the region?
The report will be introduced by the comments of H.E. Jaime Manalich, Minister of Health of Chile; Ms. Maria Teresa Valenzuela, Director of ISP; Ms. Maria Angélica Sanchez, Executive Director of ASILFA; and Mr. José Manuel Cousino Lagarrigue, Executive Director of CIF. Following the introduction, we will feature the comments of CEOs and Presidents of the major international and national pharmaceutical laboratories active in Chile.
In anticipation of the report’s publication this fall, select interviews will be regularly posted on pharma.focusreports.net
About Focus Communication
Focus Communication is a specialist B2B communications group uniquely positioned to promote business in government and strategic industries around the world. With offices in Geneva, Moscow and Paris, the agency offers core competency in e-media & e-portal creation, event planning, PR, contract publishing, marketing solutions, media consultancy, business intelligence, and more. Industries in which Focus Communication has proven expertise include aerospace & air transport, defense, mining and metals, nuclear energy, oil & gas, pharmaceuticals, power generation, and renewable energy.
| Type: | NORMAL |